BioSpace News Archive

RedHill Biopharma Ltd., a specialty biopharmaceutical company, has received a Notice of Allowance from the United States Patent and Trademark Office (USPTO) and an Intention to Grant from the European Patent Office (EPO) for two new patents covering RHB-104, expected to be valid until at least February 5, 2029, once granted.

Advicenne (Paris:ADVIC), a specialist pharmaceutical company focused on the development of pediatric-friendly therapeutics for the treatment of orphan renal and neurological diseases, announces preliminary results of the Phase III Extension Study.

Officials at FirstCare Health Plans announced an exciting initiative to bring GoNoodle and its infectiously energetic programming to over 26,000 students and 1,400 teachers in 63 Amarillo elementary schools through May 2021.

Largest Verdict In The USA for 2018 Fieger hails jurors as heroes

Young Innovations announced the acquisition of Promident, LLC

Cigna Corporation announced that Mark McClellan, M.D., has been appointed to Cigna’s Board of Directors. Dr. McClellan’s appointment is effective December 1, 2018

Titan Pharmaceuticals, Inc. (NASDAQ: TTNP), a company developing proprietary therapeutics for the treatment of select chronic diseases utilizing its ProNeura™ long-term, continuous drug delivery technology, announced today that the independent Data Safety Monitoring Board (“DSMB”) for the company’s Phase 1/2 trial...

Designed to meet the demanding needs of the biotech industry

On June 28, doctors at Morton Plant Hospital became the first in Florida to treat a patient in the APOLLO Transcatheter Mitral Valve Replacement (TMVR) Pivotal Trial.

Healthcare technology company equipped with scalable solutions for data privacy, consent management and de-identification of personal data